Machine Perfusion of the Liver: A Review of Clinical Trials.

hypothermic liver perfusion liver perfusion clinical trials machine liver perfusion machine perfusion clinical trials normothermic liver perfusion

Journal

Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127

Informations de publication

Date de publication:
2021
Historique:
received: 02 11 2020
accepted: 01 03 2021
entrez: 12 4 2021
pubmed: 13 4 2021
medline: 13 4 2021
Statut: epublish

Résumé

Although efforts have been made by transplant centers to increase the pool of available livers by extending the criteria of liver acceptance, this practice creates risks for recipients that include primary non-function of the graft, early allograft dysfunction and post-operative complications. Donor liver machine perfusion (MP) is a promising novel strategy that not only decreases cold ischemia time, but also serves as a method of assessing the viability of the graft. In this review, we summarize the data from liver machine perfusion clinical trials and discuss the various techniques available to date as well as future applications of machine perfusion. A variety of approaches have been reported including hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP); the advantages and disadvantages of each are just now beginning to be resolved. Important in this effort is developing markers of viability with lactate being the most predictive of graft functionality. The advent of machine perfusion has also permitted completely ischemia free transplantation by utilization of

Identifiants

pubmed: 33842530
doi: 10.3389/fsurg.2021.625394
pmc: PMC8033162
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

625394

Subventions

Organisme : NIAID NIH HHS
ID : R25 AI147393
Pays : United States

Informations de copyright

Copyright © 2021 Serifis, Matheson, Cloonan, Rickert, Markmann and Coe.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Curr Opin Organ Transplant. 2016 Jun;21(3):308-14
pubmed: 26918882
Cryobiology. 2003 Jun;46(3):284-8
pubmed: 12818219
Am J Transplant. 2016 Jun;16(6):1779-87
pubmed: 26752191
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1507-1515
pubmed: 28645651
J Thorac Cardiovasc Surg. 1987 Jan;93(1):11-8
pubmed: 3540455
Transplantation. 2019 Jul;103(7):1405-1413
pubmed: 30395120
Am J Transplant. 2012 Sep;12(9):2477-86
pubmed: 22594953
Best Pract Res Clin Anaesthesiol. 2008 Mar;22(1):63-80
pubmed: 18494389
Ann Thorac Surg. 2007 Jun;83(6):2191-4
pubmed: 17532422
Nature. 2018 May;557(7703):50-56
pubmed: 29670285
Am J Transplant. 2016 Nov;16(11):3235-3245
pubmed: 27192971
Liver Transpl. 2018 Oct;24(10):1453-1469
pubmed: 30359490
Curr Opin Organ Transplant. 2018 Jun;23(3):347-352
pubmed: 29629996
PLoS One. 2015 Oct 29;10(10):e0139791
pubmed: 26513368
Liver Transpl. 2018 Apr;24(4):528-538
pubmed: 29281862
Transplantation. 2017 Nov;101(11):2746-2756
pubmed: 28520579
Transplant Direct. 2016 Aug 05;2(9):e97
pubmed: 27795989
Nat Commun. 2020 Jun 16;11(1):2939
pubmed: 32546694
Am J Transplant. 2015 Feb;15(2):381-94
pubmed: 25612645
Am J Transplant. 2012 Jul;12(7):1824-30
pubmed: 22578189
Clin Transplant. 2020 Mar;34(3):e13790
pubmed: 31984571
Transplantation. 2017 May;101(5):1084-1098
pubmed: 28437389
Nat Biotechnol. 2020 Feb;38(2):189-198
pubmed: 31932726
Acta Pharmacol Sin. 2018 May;39(5):845-857
pubmed: 29565040
J Hepatol. 2013 Nov;59(5):984-91
pubmed: 23820408
Ann Surg. 2015 Nov;262(5):764-70; discussion 770-1
pubmed: 26583664
Hepatology. 2019 Aug;70(2):682-695
pubmed: 30561835
Ann Surg. 2019 Nov;270(5):906-914
pubmed: 31633615
Am J Transplant. 2019 Apr;19(4):1202-1211
pubmed: 30588774
Am J Transplant. 2015 Jan;15(1):161-9
pubmed: 25521639
Am J Transplant. 2010 Feb;10(2):372-81
pubmed: 19958323
Liver Transpl. 2019 Jun;25(6):848-858
pubmed: 30938039
HPB (Oxford). 2017 Jun;19(6):538-546
pubmed: 28351756
Liver Transpl. 2019 Oct;25(10):1503-1513
pubmed: 31206217
Am J Transplant. 2013 May;13(5):1327-35
pubmed: 23463950
Transplantation. 1993 Jun;55(6):1265-72
pubmed: 7685932
J Surg Res. 2011 May 15;167(2):e365-73
pubmed: 20451921
Liver Transpl. 2018 May;24(5):655-664
pubmed: 29369470
Am J Transplant. 2018 Aug;18(8):2005-2020
pubmed: 29419931
J Hepatol. 2019 Jan;70(1):50-57
pubmed: 30342115
Ann Surg. 2014 Nov;260(5):931-7; discussion 937-8
pubmed: 25243553
Liver Transpl. 2019 Mar;25(3):436-449
pubmed: 30362649
Br J Surg. 2017 Jun;104(7):907-917
pubmed: 28394402
Ann Transl Med. 2018 Oct;6(20):409
pubmed: 30498736
Am J Transplant. 2019 Jun;19(6):1745-1758
pubmed: 30589499
Am J Transplant. 2018 Mar;18(3):737-744
pubmed: 29127685
Ann Transplant. 2018 Apr 20;23:258-267
pubmed: 29674604
Am J Transplant. 2019 Apr;19(4):1061-1071
pubmed: 30411502
Liver Transpl. 2019 Jul;25(7):1007-1022
pubmed: 30821045

Auteurs

Nikolaos Serifis (N)

Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, United States.

Rudy Matheson (R)

Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, United States.

Daniel Cloonan (D)

Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, United States.

Charles G Rickert (CG)

Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, United States.

James F Markmann (JF)

Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, United States.

Taylor M Coe (TM)

Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, United States.

Classifications MeSH